Metropolitan Life Insurance Company (MetLife)’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,903
| Closed | -$164K | – | 2656 |
|
|
2018
Q2 | $164K | Buy |
2,903
+929
| +47% | +$52.6K | ﹤0.01% | 2064 |
|
|
2018
Q1 | $83.5K | Sell |
1,974
-66
| -3% | -$2.79K | ﹤0.01% | 2366 |
|
|
2017
Q4 | $109K | Sell |
2,040
-4,204
| -67% | -$225K | ﹤0.01% | 2261 |
|
|
2017
Q3 | $279K | Buy |
6,244
+37
| +0.6% | +$1.65K | ﹤0.01% | 2072 |
|
|
2017
Q2 | $302K | Hold |
6,207
| – | – | ﹤0.01% | 2064 |
|
|
2017
Q1 | $449K | Buy |
6,207
+398
| +7% | +$28.8K | ﹤0.01% | 1724 |
|
|
2016
Q4 | $332K | Sell |
5,809
-263
| -4% | -$15K | ﹤0.01% | 2026 |
|
|
2016
Q3 | $777K | Sell |
6,072
-232
| -4% | -$29.7K | 0.01% | 1429 |
|
|
2016
Q2 | $786K | Buy |
6,304
+847
| +16% | +$106K | 0.01% | 1404 |
|
|
2016
Q1 | $456K | Buy |
5,457
+569
| +12% | +$47.5K | ﹤0.01% | 1634 |
|
|
2015
Q4 | $484K | Hold |
4,888
| – | – | ﹤0.01% | 1643 |
|
|
2015
Q3 | $599K | Hold |
4,888
| – | – | ﹤0.01% | 1521 |
|
|
2015
Q2 | $750K | Sell |
4,888
-224
| -4% | -$34.4K | 0.01% | 1486 |
|
|
2015
Q1 | $873K | Hold |
5,112
| – | – | 0.01% | 1274 |
|
|
2014
Q4 | $782K | Hold |
5,112
| – | – | 0.01% | 1484 |
|
|
2014
Q3 | $542K | Hold |
5,112
| – | – | ﹤0.01% | 1667 |
|
|
2014
Q2 | $777K | Hold |
5,112
| – | – | 0.01% | 1527 |
|
|
2014
Q1 | $658K | Hold |
5,112
| – | – | ﹤0.01% | 1612 |
|
|
2013
Q4 | $891K | Hold |
5,112
| – | – | 0.01% | 1403 |
|
|
2013
Q3 | $824K | Buy |
5,112
+274
| +6% | +$44.2K | 0.01% | 1407 |
|
|
2013
Q2 | $642K | Buy |
+4,838
| New | +$642K | 0.01% | 1529 |
|